Ramucirumab for advanced gastric or GEJ adenocarcinoma in previously treated patients with disease progression

被引：0
|
作者：
Abraham, Jame
机构：
来源：
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY | 2014年 / 12卷 / 12期
关键词：
D O I：
10.12788/jcso.0093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：428 / 430
页数：3
相关论文
共 50 条
  • [1] A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma
    Satoshi Murahashi
    Daisuke Takahari
    Takeru Wakatsuki
    Naoki Fukuda
    Takashi Ichimura
    Mariko Ogura
    Masato Ozaka
    Eiji Shinozaki
    Izuma Nakayama
    Tomohiro Matsushima
    Hiroki Osumi
    Keisho Chin
    Kensei Yamaguchi
    [J]. International Journal of Clinical Oncology, 2018, 23 : 92 - 97
  • [2] A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma
    Murahashi, Satoshi
    Takahari, Daisuke
    Wakatsuki, Takeru
    Fukuda, Naoki
    Ichimura, Takashi
    Ogura, Mariko
    Ozaka, Masato
    Shinozaki, Eiji
    Nakayama, Izuma
    Matsushima, Tomohiro
    Osumi, Hiroki
    Chin, Keisho
    Yamaguchi, Kensei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (01) : 92 - 97
  • [3] A phase 1/2 study of ramucirumab plus nivolumab in patients with previously treated advanced gastric adenocarcinoma
    Shoji, H.
    Miyamoto, H.
    Hara, H.
    Takahari, D.
    Machida, N.
    Esaki, T.
    Nagashima, K.
    Aoki, K.
    Honda, K.
    Nagata, Y.
    Miyamoto, T.
    Boku, N.
    Kato, K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [4] Ramucirumab (R) plus pembrolizumab (P) in treatment naive and previously treated advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: A multi-disease phase I study.
    Chau, Ian
    Bendell, Johanna C.
    Calvo, Emiliano
    -Davila, Rafael Santana
    Arkenau, Hendrik-Tobias
    Mi, Gu
    Jin, Jin
    Rege, Jessicca
    Ferry, David
    Herbst, Roy S.
    Fuchs, Charles S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Previously treated Patients with advanced Gastric Cancer Ramucirumab: Important Expansion in Palliative Therapy
    不详
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (05) : 308 - 308
  • [6] Safety and efficacy of ramucirumab (R) plus pembrolizumab (P) in treatment naive and previously treated advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: a multi-disease phase 1 study
    Thuss-Patience, P.
    Vasile, E.
    Chau, I
    Penel, N.
    Mi, G.
    Emig, M.
    Fuchs, C. S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 254 - 255
  • [7] Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma.
    Park, Haeseong
    Trikalinos, Nikolaos
    Sanjeevaiah, Aravind
    Pedersen, Katrina
    Bagegni, Nusayba Ali
    Nixon, Andrew B.
    Huffman, Jesse
    Tan, Benjamin R.
    Suresh, Rama
    Lim, Kian-Huat
    Amin, Manik A.
    Wang-Gillam, Andrea
    Lockhart, A. Craig
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Tolerability and quality-of-life (QoL) results from the phase REGARD study: Ramucirumab versus placebo in patients with previously treated gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Chau, I.
    Passalacqua, R.
    Zalcberg, J. R.
    Fuchs, C. S.
    Liepa, A. M.
    Hsu, Y.
    Schwartz, J. D.
    Koshiji, M.
    Tabernero, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S615 - S615
  • [9] Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology
    Galle, Peter R.
    Kudo, Masatoshi
    Llovet, Josep M.
    Finn, Richard S.
    Karwal, Mark
    Pezet, Denis
    Kim, Tae-You
    Yang, Tsai-Sheng
    Lonardi, Sara
    Tomasek, Jiri
    Phelip, Jean-Marc
    Touchefeu, Yann
    Koh, Su-Jin
    Stirnimann, Guido
    Liang, Kun
    Ogburn, Kenyon D.
    Wang, Chunxiao
    Abada, Paolo
    Widau, Ryan C.
    Zhu, Andrew X.
    [J]. LIVER INTERNATIONAL, 2021, 41 (11) : 2759 - 2767
  • [10] Preliminary result of phase 1/2 study of ramucirumab plus nivolumab in patients with previously treated advanced gastric adenocarcinoma (NivoRam study).
    Takahari, Daisuke
    Shoji, Hirokazu
    Hara, Hiroki
    Esaki, Taito
    Machida, Nozomu
    Nagashima, Kengo
    Aoki, Kazunori
    Honda, Kazufumi
    Miyamoto, Takahiro
    Boku, Narikazu
    Kato, Ken
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345